RAPEX System 2019 Report
Every week, the RAPEX system publishes notifications of urgent measures taken by EU Member-States to prevent, restrict or impose conditions on the marketing of products due to the serious and immediate danger they pose to the health and safety of consumers.

Date

Marta Pinto

Marta Pinto

Regulatory Affairs Associate

RAPEX NETWORK 

In 2005, the European Union (EU) set up the rapid alert system (RAPEX) for dangerous non-food products, based on the General Product Safety Directive (Directive 2001/95/EC). The aim of this system is to accelerate the information exchange and cooperation on product safety. In 2010, this network included also alerts on products posing other risks (other than for health or safety), such as environmental risks, and products exclusively for professional use. Food, pharmaceutical products or medical devices are not included in the RAPEX system. 

Through this system, national authorities (responsible for product safety) are able to send alerts to the European Commission, where they report the measures taken against products posing a risk. After checking all the information reported, the Commission publicly publishes it on the ‘Safety Gate’ website, informing consumers about dangerous products. 

Companies have the responsibility to place safe products on the market and the national authorities need to check if the companies comply with their obligations, conducting regular inspections and sampling of products for testing. The Product Safety Business Alert Gateway is the tool set up by the Commission to facilitate companies reporting. Consumers may also report dangerous products to the national authorities. 

2019 RAPEX REPORT – COSMETICS 

In 2019, there were 2243 alerts received in the system on measures taken against dangerous products. There were 4477 follow-up actions taken by the competent authorities in response to the alerts concerning dangerous products. 

96 cosmetic products (sold in shops or internet) from 27 countries were subject to withdrawal, recall or prohibition of marketing (6% of notifications reported). From these, skin lightening products, perfumes, body care and hair dyes accounted for more than half of the notifications for cosmetics (approximately 56%). Almost 60% of notifications concerning cosmetics are justified by the presence of prohibited ingredients (e.g. MI/MIT, certain colorants, heavy metals, formaldehyde, medicinal substances, hydroquinone), whilst 18.75% are due to microbiological contamination.

National authorities have detected chemicals which can result in serious risks to consumers’ health and safety. For example, in 2019, 10 alerts concerned cosmetic products containing mercury. This metal has the ability to accumulate in the human body, damage the kidneys, brain and nervous system and can affect reproduction. 

Carcinogenicity is a significant hazard that remains amongst the potential health effects. Compared to the previous year, there was a slight decrease in the alerts involving products containing substances which may induce cancer in long term (such as cosmetics, tattoo inks and toys) reported on the Safety Gate (2019). Aromatic amines and nitrosamines, nitrosatable substances, polycyclic aromatic hydrocarbons (which interfere with DNA) and cadmium are among the chemicals commonly detected and that continue a key source of concern.  

Tattoo inks may contain several chemical components that may pose risks to the health of consumers and also to the professionals handling such products. Polycyclic aromatic hydrocarbons, benzo[a]pyrene, cadmium and lead were detected in tattoo inks and can lead to serious health problems.  

Another cause of concern are the products made available online. 16% of the alerts in 2019 mentioned that the dangerous products were sold online. Checking and testing these products can be tricky, especially if the seller is located outside the EU. 

References: 

  1. European Commission – 2019 Results of the Rapid Alert System for dangerous non-food products. Available at: https://ec.europa.eu/consumers/consumers_safety/safety_products/rapex/alerts/repository/content/pages/rapex/reports/docs/RAPEX.2019.report.EN.pdf 
  1. Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32001L0095&from=EN 

further
reading

cosmetic products

BREXIT e os Produtos Cosméticos Comercializados em Portugal

No passado dia 22 deste mês, o INFARMED, I.P., emitiu uma Circular Informativa, onde concede um período transitório de 6 meses às empresas, cuja Pessoa Responsável está sediada no Reino Unido e que desejam continuar a ter os seus produtos cosméticos disponíveis no mercado nacional, para que possam enviar toda a documentação e informação necessárias.

Read More »
cosmetic products

Virginia – The Fourth State to Ban Animal Testing in the U.S.

In the United States (U.S.), Virginia is the fourth state to ban animal testing in cosmetic products. The Governor of this state (Ralph Northam) has signed this month (March 2021) a bill and the ban will start on January 1st, 2022. The sale of cosmetics tested on animals will also be prohibited from July 1st, 2022.

Read More »
cosmetic products

France Anti-Waste Law

On February 11th, 2020, the Loi relative à la lute contre le gaspillage et a l’économie circulaire (Anti-Waste for a circular economy) has come officially into force in France. The law provides for a ban on all single-use plastics by 2040.

Read More »
cosmetic products

EU Reduction of the Impact of Certain Plastic Products on the Environment

Cosmetics and personal care industry are a growing business, but with this growth comes a major concern: plastic pollution.
The European Commission has published the Directive (EU) 2019/904, known as Single-Use Plastic Directive. This directive addresses the reduction of the impact of certain plastic products on the environment. Harmonized marking specifications are laid down on the Commission Implementing Regulation (EU) 2020/2151.

Read More »
medical devices

BREXIT – Impact on Medical Devices placed in the UK market

From 31 of December 2020, the UK will be regarded as a third country and not a Member State of the European Union. There will be some changes regarding medical devices placed in the UK. The UK’s MHRA has published guidance regarding the regulation of medical devices from 1 January 2021, where it explains what changes and what there is to know about placing a medical device in the Great Britain, Northern Ireland and EU markets.

Read More »
medical devices

Brazil – Class II Medical Devices – New Resolution

A new Resolution of the Collegiate Board of Directors (RDC No. 423/2020) has been published by Brazil’s National Agency of Health Surveillance (ANVISA). This new Resolution announces the elimination of the ‘Cadastro’ pathway regarding the registration of medical devices (Class II) and IVDs, substituting it with a notification registration system.

Read More »
cosmetic products

Butylphenyl Methylpropional to be prohibited in cosmetics placed in the EU market

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation (Commission Delegated Regulation No. 2020/1182), Butylphenyl Methylpropional is now classified as toxic to reproduction (Repr. 1B – CMR 1B) and it shall be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

China Bans Microbeads in Cosmetics

On 16th January 2020, China’s National Development and Reform Commission (NDRC) issued the Notice [2020] No. 80, with the aim of prohibiting the use of microbeads in cosmetics and personal care products. More detailed information was given in the Notice [2020] No. 1146, issued by the NDRC on 10th July 2020.

Read More »
medical devices

EU Medical Devices Regulation – Unique Device Identifier (UDI)

In 2017, two Regulations on medical devices (MDR) and in in vitro diagnostic medical devices (IVDR) entered into force in the European Union (EU), establishing a modernized and more robust EU legislative framework and safeguarding a better public health protection and patient safety. According to the these Regulations, the Unique Device Identifier (UDI) will be mandatory for all medical devices and in vitro medical devices.

Read More »
COVID-19

FDA updates on hand sanitizers safety for use

The U.S. Food and Drug Administration (FDA) has announced that it is providing a new laboratory testing method to assess the quality of finished hand sanitizers. Moreover, the FDA has issued a new press release on August 27th 2020, where it warns consumers about hand sanitizers packaged in food and drink containers. Earlier this month, the FDA expanded hand sanitizer warnings to include 1-propanol contamination.

Read More »
cosmetic products

RAPEX System 2019 Report

Every week, the RAPEX system publishes notifications of urgent measures taken by EU Member-States to prevent, restrict or impose conditions on the marketing of products due to the serious and immediate danger they pose to the health and safety of consumers.

Read More »
cosmetic products

Cosmetic Packaging in European Union

Packaging material is defined as the container (or primary packaging) that is in direct contact with the formulation. According to the European Cosmetic Regulation No. 1223/2009, packaging evaluation is mandatory to guarantee cosmetic product safety. To meet this Regulation requirements, the European Commission issued the Decision 2013/674/EU, establishing guidelines on the practical application of such requirements and identifying information that should be collected on the packaging materials and the potential migration of substances from packaging.

Read More »